3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Coeliac Disease: new trials by email Literature Review of Coeliac Disease trials Research Report on Coeliac Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK3915393 in Healthy Participants and to Evaluate the Interaction Between GSK3915393 and Grapefruit Juice and Itraconazole GSK3915393 Capsules, GSK3915393 Solution for Infusion, Placebo capsules - Celiac Disease, Coeliac Disease | Phase 1 | Completed | GlaxoSmithKline | 65 | 2020-11-04 | 2023-05-09 |
| Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease Nexvax2, Placebo - Celiac Disease, Intestinal Disease | Phase 1 | Completed | ImmusanT, Inc. | 14 | 2018-05-01 | 2018-09-20 |
| Safety Study of Nexvax2 in Subjects With Coeliac Disease 9 micrograms Nexvax2, 30 micrograms Nexvax2, 90 micrograms Nexvax2 - Coeliac Disease, Celiac Disease | Phase 1 | Completed | Nexpep Pty Ltd | 34 | 2009-04-01 | 2011-04-07 |
Celiac Disease (3) · Digestive System Diseases (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1) · Malabsorption Syndromes (1) · Metabolic Diseases (1)
Nutritional and Metabolic Diseases (3) · Digestive System Diseases (2) · Gastrointestinal Diseases (2) · Intestinal Diseases (2) · Malabsorption Syndromes (2) · Metabolic Diseases (2)
Itraconazole (1) · Nexvax2 (1) · Water (1)
GlaxoSmithKline (1) · ImmusanT, Inc. (1) · Nexpep Pty Ltd (1)
Australia (2) · United Kingdom (1)
Gregor Brown, MBBS PhD FRACP (1) · James Daveson, MBBS FRACP (1) · Robert Anderson, PhD, FRACP (1)